News

Unlocking Insights: Annual IT Solution Provider Salary Survey

Unlocking Insights: Annual IT Solution Provider Salary Survey

Service Leadership Kicks Off Annual Compensation Survey

Service Leadership, Inc., part of ConnectWise, has officially opened submissions for its much-anticipated Annual IT Solution Provider Compensation Survey. This initiative is imperative for IT solution providers aiming to stay competitive in today’s fast-evolving landscape.

Understanding the Importance of the Survey

The Annual IT Solution Provider Compensation Report delivers invaluable insights into salary trends for various positions within the IT sector. This year, the survey expands its scope to cover emerging roles in artificial intelligence (AI) and robotic process automation (RPA), addressing a significant shift in the sector's demand for new talent.

AI Roles Taking Center Stage

“AI is rapidly reshaping the IT solution provider industry,” remarks Peter Kujawa, EVP & GM, Service Leadership & IT Nation. The growing importance of AI introduces new job descriptions and responsibilities, which the survey aims to capture, offering essential wage data for these evolving roles.

Survey Details and Participation

The survey encompasses over 50 distinct IT roles ranging from sales and marketing to technical services, analyzing data across three seniority levels. This comprehensive collection of information includes in-depth details about total compensation, including base salaries and incentive plans.

What Participants Can Expect

All participating IT solution providers will receive the Service Leadership Index Annual Compensation Report at no cost—a value of USD $1,999. Additionally, early findings on wage inflation trends will be shared exclusively with participants in December, aiding them in 2026 budgeting and planning.

Timing and Significance

The survey is open from the start of October through the end of November, giving providers ample time to contribute data that will shape the future of compensation strategies in the sector. By analyzing this data, service providers can make informed decisions that enhance their talent recruitment and retention efforts.

About Service Leadership

Service Leadership, Inc. is committed to offering comprehensive profit solutions for IT solution providers through precise benchmarking and analysis. They publish the renowned Service Leadership Index, which serves as a vital resource for IT organizations seeking to evaluate their financial health and operational effectiveness.

The SLIQ Application

An added feature is SLIQ, a web application designed for partner owners and executives. This tool allows users to assess their Operational Maturity Level confidentially, helping drive financial enhancement through strategic metrics.

The Role of ConnectWise

ConnectWise stands as a leader in providing technological solutions for managed service providers (MSPs). With decades of experience, the firm empowers small to midsized businesses across the globe with competitive software, automation, and integrations that foster growth.

Innovation at ConnectWise

Through the ConnectWise Asio™ platform, which is powered by innovative AI capabilities, the company supplies an all-encompassing technology stack that meets the unique needs of MSPs, including tools for project management, remote monitoring, and cybersecurity efforts.

Conclusion

In a time where AI and technology are continuously reshaping industries, the Service Leadership Annual IT Solution Provider Compensation Survey plays a pivotal role in ensuring IT businesses remain agile and competitive. By participating in this survey, companies can not only gain access to crucial data but also contribute to shaping salary standards in the IT sector.

Frequently Asked Questions

What is the purpose of the Annual IT Solution Provider Compensation Survey?

The survey aims to collect and analyze compensation data for various IT roles, helping providers understand market trends and make informed hiring decisions.

How many roles does the survey cover?

The survey examines over 50 IT roles across different functions and seniority levels, providing a comprehensive look at compensation practices.

What new roles are included in this year's survey?

This year's survey includes emerging roles in artificial intelligence (AI) and robotic process automation (RPA), reflecting current market demands.

When does the survey take place?

The survey is open from October 1 to November 30, allowing ample time for participation and data collection.

What benefits do participants receive?

Participants will receive the compensation report at no cost and early insights into wage inflation for better budgeting strategies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 149

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 118

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 202

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 179

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 109

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading

Top 5 Most Recently Viewed Articles

Kimbell Royalty Partners Engages Investors at Key Conferences

Updated Category News Views 101

Kimbell Royalty Partners to Attend Notable Investor Conferences Kimbell Royalty Partners, LP (NYSE: KRP) is a prominent owner of oil and natural gas mineral and royalty interests. The company proudly manages over 129,000 gross wells across multiple states. In an effort to strengthen investor relations and share its strategic outlook, Kimbell has announced its...

Continue Reading
Karsan's Autonomous Bus Debuts at Efteling Park

Updated Category News Views 72

A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....

Continue Reading
EyePoint Pharmaceuticals Expands Workforce with Stock Options

Updated Category News Views 301

EyePoint Pharmaceuticals Expands Workforce with Stock Options EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a dynamic biopharmaceutical company, is on a mission to enhance the lives of patients facing serious retinal diseases. Recently, the company made a notable announcement regarding the expansion of its team through the granting of non-statutory stock options to new...

Continue Reading
IonQ Shares: Insights Into Their Current Market Performance

Updated Category News Views 204

Overview of IonQ's Current Stock Performance IonQ Inc. IONQ shares have seen a notable decline recently, continuing a downward trend that’s persisted over the last couple of weeks. As the company gears up to announce its second-quarter earnings, investors are closely monitoring the developments, particularly the anticipated shift in stock momentum. Market Sentiment and...

Continue Reading
Exploring the Promising CD47 Inhibitor Drug Market Growth

Updated Category News Views 40

Understanding the CD47 Inhibitor Drug Market Gaining insights into the CD47 inhibitor drug market is crucial for recognizing the changes and advancements in cancer immunotherapy. These drugs play a vital role in the battle against cancer by harnessing the body's immune system to identify and eliminate malignant cells. CD47's Role in Cancer CD47, often referred to as the...

Continue Reading